BUB
REGN icon

BBVA USA Bancshares’s Regeneron Pharmaceuticals REGN Stock Holding History

BBVA USA Bancshares’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$6.68M Sell
14,122
-1,295
-8% -$631K 0.32% 85
2020
Q4 		$7.45M Sell
15,417
-2,366
-13% -$1.28M 0.38% 70
2020
Q3 		$10M Sell
17,783
-986
-5% -$598K 0.57% 38
2020
Q2 		$11.7M Buy
18,769
+92
+0.5% +$52.2K 0.7% 28
2020
Q1 		$9.12M Buy
18,677
+2,059
+12% +$849K 0.65% 33
2019
Q4 		$6.24M Sell
16,618
-759
-4% -$255K 0.35% 70
2019
Q3 		$4.82M Buy
17,377
+1,059
+6% +$313K 0.31% 90
2019
Q2 		$5.11M Sell
16,318
-87
-0.5% -$29K 0.31% 86
2019
Q1 		$6.74M Buy
16,405
+778
+5% +$320K 0.42% 59
2018
Q4 		$5.84M Sell
15,627
-60
-0.4% -$22K 0.42% 61
2018
Q3 		$6.34M Buy
15,687
+1,078
+7% +$410K 0.38% 67
2018
Q2 		$5.04M Buy
14,609
+3,490
+31% +$1.09M 0.32% 79
2018
Q1 		$3.83M Sell
11,119
-19
-0.2% -$6.61K 0.25% 97
2017
Q4 		$4.19M Sell
11,138
-2,401
-18% -$972K 0.27% 90
2017
Q3 		$6.05M Sell
13,539
-598
-4% -$285K 0.4% 62
2017
Q2 		$6.94M Buy
14,137
+795
+6% +$348K 0.46% 55
2017
Q1 		$5.17M Buy
13,342
+3,119
+31% +$1.16M 0.35% 72
2016
Q4 		$3.75M Buy
10,223
+5,911
+137% +$2.25M 0.26% 92
2016
Q3 		$1.73M Buy
+4,312
New +$1.73M 0.13% 162
2016
Q1 		– Sell
-707
Closed -$384K – 512
2015
Q4 		$384K Buy
707
+1
+0.1% +$542 0.03% 374
2015
Q3 		$328K Hold
706
– – 0.03% 375
2015
Q2 		$360K Hold
706
– – 0.02% 403
2015
Q1 		$319K Hold
706
– – 0.01% 472
2014
Q4 		$290K Buy
706
+3
+0.4% +$1.18K 0.01% 480
2014
Q3 		$253K Buy
+703
New +$236K 0.01% 501
2014
Q2 		– Sell
-706
Closed -$212K – 556
2014
Q1 		$212K Buy
+706
New +$218K 0.01% 516

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BBVA USA Bancshares's REGN Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Regeneron Pharmaceuticals (REGN) stake by 8.4% in Q1 2021, selling an estimated $631K and leaving 14,122 shares worth $6.68M. The position accounts for 0.32% of the portfolio, ranked #85.

BBVA USA Bancshares first reported a position in REGN in Q1 2014 and has held it in 26 quarters since. The position peaked at $11.7M in Q2 2020. 925 funds tracked by Wall St. Rank hold REGN as of Q1 2021.

  • BBVA USA Bancshares held 14,122 shares of Regeneron Pharmaceuticals worth $6.68M as of Q1 2021.
  • BBVA USA Bancshares sold 1,295 Regeneron Pharmaceuticals shares in Q1 2021, an estimated $631K.
  • Regeneron Pharmaceuticals made up 0.32% of BBVA USA Bancshares's portfolio in Q1 2021, its #85 holding.
  • BBVA USA Bancshares first reported a position in Regeneron Pharmaceuticals in Q1 2014 and has held it in 26 quarters since.
  • BBVA USA Bancshares's Regeneron Pharmaceuticals position peaked at $11.7M in Q2 2020.
  • 925 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.